Every price names its source
No sponsorships, referrals or clinic partnerships
EpiPen, insulin & Ozempic prices refreshed October 2026
Cost comparison only — not medical advice
Every price names its source
No sponsorships, referrals or clinic partnerships
EpiPen, insulin & Ozempic prices refreshed October 2026
Cost comparison only — not medical advice
← All Articles
Investigation

US Health Care Costs 2024: $15,474 Per Person, 18% of GDP

Independent investigation: seven structural drivers behind the US cost premium

Researched with AI assistance; every figure is checked against the primary source cited on this page before publishing. How we work →

Key Takeaways

  • $15,474 per person in 2024 — total US health spending reached $5.3 trillion (18.0% of GDP), per CMS National Health Expenditure Accounts. On the basis used for international comparison, the US spent $14,775 per person — about 1.9× the $7,860 average of comparable wealthy countries (Peterson-KFF).
  • Worst outcomes among peers. The Commonwealth Fund's 2024 Mirror Mirror report ranks the US health system 10th of 10 high-income countries overall, and last on access to care and health outcomes; the US scores well only on care process (2nd). US life expectancy was 79.0 years in 2024 (CDC), versus 84.1 in Japan (OECD, 2023).
  • Seven structural drivers explain the gap — not one of them is "individual choice." Layered middlemen, admin overhead, brand drug pricing, hospital consolidation, defensive medicine, price opacity, and employer-tied insurance compound into a system that bills more for less.
  • Millions without financial protection. 26.7 million under-65s were uninsured in 2024 (KFF), and 23% of all working-age adults had coverage all year yet were underinsured (Commonwealth Fund, 2024).
  • Reform is moving, slowly. Medicare Drug Negotiation (IRA 2022, effective 2026), the Hospital Price Transparency Rule, and the No Surprises Act target specific layers — but the paradox persists: highest spending, worst peer outcomes.

How Much Does the US Spend on Health Care? (2024 Figures)

The United States spent $5.3 trillion on health care in 2024 — $15,474 per person, equal to 18.0% of gross domestic product — and total spending grew 7.2% over 2023 (CMS National Health Expenditure Accounts).

Three per-person figures circulate, and each measures something different. $15,474 is total national health expenditure, including investment in research, structures and equipment. $14,775 is health consumption expenditure (CMS Table 1), the figure the Peterson-KFF Health System Tracker uses in the country table below. $14,885 is the OECD's purchasing-power-adjusted estimate of current health spending, published in November 2025 as a provisional figure. The share of GDP differs for the same reason: 18.0% (CMS, total) versus 17.2% (OECD, current health spending).

On the OECD's figures, the US spent about 2.5 times the OECD average per person in 2024: $14,885 versus $5,967. The OECD average share of GDP spent on health was 9.3%; the US spent 17.2%, "well above Germany, the next highest spender (at 12.3%)". Per person, Germany spent $9,365, France $7,367 and the United Kingdom $6,747 (OECD, Health at a Glance 2025, provisional 2024 data).

Per-Capita Health Spending: US vs Peer Countries

Per-capita health consumption spending in 2024, current US dollars adjusted for purchasing-power parity (Peterson-KFF Health System Tracker, using CMS and OECD data). This comparable basis is narrower than CMS's total figure of $15,474 per person.

Country Per Capita % of GDP vs US Source
United States $14,775 17.2% Reference Peterson-KFF Health System Tracker (CMS NHE data), 2024
Germany $9,365 12.3% 37% less Peterson-KFF (OECD Health Statistics), 2024
Canada $7,301 11.3% 51% less Peterson-KFF (OECD Health Statistics), 2024
United Kingdom $6,747 11.1% 54% less Peterson-KFF (OECD Health Statistics), 2024
Japan $5,790 10.6% 61% less Peterson-KFF (OECD Health Statistics), 2024
Comparable-country average $7,860 11.2% 47% less Peterson-KFF (OECD Health Statistics), 2024

Data year 2024 (Peterson-KFF Health System Tracker, using CMS National Health Expenditure data and OECD Health Statistics; page dated March 11, 2026).

Seven Structural Drivers

The cost gap is not explained by individual consumer behavior, technological innovation, or sicker patients. It is the cumulative result of seven documented structural drivers, each anchored to peer-reviewed or regulatory sources.

  1. Layered Middlemen

    The top 3 PBMs control 79% of US prescription claims (FTC Interim Staff Report, July 2024). Each layer — insurer, PBM, group purchasing organization, third-party administrator — extracts margin without delivering care.

  2. Administrative Overhead

    In 2017, administration consumed 34.2% of US health spending ($2,497 per person) versus 17.0% in Canada ($551) (Himmelstein & Woolhandler, Annals of Internal Medicine, 2020).

  3. Brand Drug Prices

    In 2022, US drug prices were 2.78× those in 33 other OECD countries across all drugs, and 4.22× for brand-name drugs before rebates (RAND, 2024). For insulin, the average US manufacturer price per standard unit was $98.70 versus $12.00 in Canada (RAND for HHS ASPE, 2018 data).

  4. Hospital Consolidation

    In 2016, 90% of US metropolitan areas had highly concentrated hospital markets (Fulton, Health Affairs 2017). Prices at monopoly hospitals are 12% higher than in markets with four or more rivals (Cooper, Craig, Gaynor, Van Reenen — QJE 2019).

  5. Defensive Medicine

    Defensive medicine was estimated at $45.6 billion in 2008, within $55.6 billion in total medical-liability costs — about 2.4% of US health spending (Mello, Chandra, Gawande, Studdert — Health Affairs 2010). The cost is embedded in every facility fee.

  6. Price Opacity

    In a November 2024 review of 2,000 US hospitals, the advocacy group PatientRightsAdvocate.org found only 21.1% fully compliant with the federal Hospital Price Transparency Rule (34.5% in its February 2024 review). Without usable prices, patients cannot shop on cost.

  7. Employer-Tied Insurance

    49% of Americans get coverage through employers; family premiums averaged $28,303 in 2026 (KFF Employer Health Benefits Survey). The tax exclusion subsidizes the system that drives admin overhead and ties coverage to jobs ('job lock').

The Paradox: Highest Spending, Worst Peer Outcomes

If higher spending bought better health outcomes, the US would be at the top of every international ranking. It is not. The Commonwealth Fund's Mirror Mirror 2024 report compares health-system performance across 10 high-income countries on five domains — access, care process, administrative efficiency, equity, and health outcomes. The US ranks last (10 of 10) overall and last on access and health outcomes, ninth on administrative efficiency and equity, and second on care process.

Life expectancy at birth in the US was 79.0 years in 2024 (CDC NCHS Data Brief 548), versus 84.1 in Japan (OECD, 2023). US maternal mortality was 17.9 deaths per 100,000 live births in 2024 — about four times the rate in Germany and Japan (4.4 each), per OECD Health Statistics. Avoidable mortality — deaths preventable through timely, effective care — is the highest in the peer group.

The paradox is not about whether US clinicians are skilled or US technology is advanced — both are world-class at the individual level. The system that organizes, finances, and prices that care is what produces the international gap. Every dollar that compounds into the seven structural drivers is a dollar that does not buy better life expectancy, lower maternal mortality, or fewer avoidable deaths.

What Uninsured and Underinsured Americans Live With

System-level statistics translate into household-level exposure. 26.7 million Americans under 65 were uninsured in 2024 (9.8%, KFF analysis of Census data). 23% of working-age adults (19–64) were underinsured in 2024 — insured all year, but with out-of-pocket costs (excluding premiums) or deductibles that were high relative to income (Commonwealth Fund 2024 Biennial Health Insurance Survey).

In a 2013–2016 survey of bankruptcy filers, 66.5% cited medical bills or illness-related income loss as a contributing factor (Himmelstein et al., AJPH 2019); other researchers using hospitalization data estimate a much smaller direct causal share (Dobkin et al., American Economic Review 2018). Surprise out-of-network bills were common before the No Surprises Act took effect in 2022, and "job lock" — staying in a job to keep employer coverage — remains a documented effect of tying insurance to employment.

These are not edge cases. They are predictable downstream effects of the seven drivers above — features of the system, not bugs.

Frequently Asked Questions

Why is US healthcare so expensive?

Seven structural drivers compound: layered middlemen (the top 3 PBMs control 79% of prescription claims), administrative overhead (34.2% of spending vs 17.0% in Canada, 2017 data), brand drug prices (4.22× other OECD countries before rebates, 2022), hospital consolidation, defensive medicine (an estimated $45.6B in 2008), price opacity (only about one in five reviewed hospitals fully complied with transparency rules in late 2024), and employer-tied insurance. None of them is 'individual choice.'

How much does the US spend on healthcare per person?

CMS National Health Expenditure Accounts put total US health spending at $15,474 per person in 2024 ($5.3 trillion, 18.0% of GDP). On the narrower basis used for international comparison, the US spent $14,775 per person in 2024 versus $9,365 in Germany, $7,301 in Canada and $6,747 in the UK (Peterson-KFF Health System Tracker using OECD data).

Does higher US spending buy better healthcare?

No. The Commonwealth Fund's 2024 Mirror Mirror report ranks the US health system 10th of 10 high-income countries on overall performance. US life expectancy was 79.0 years in 2024 versus 84.1 in Japan (2023) — highest spending, worst peer outcomes.

How many Americans are affected by high healthcare costs?

26.7 million Americans under 65 were uninsured in 2024 (9.8%, KFF analysis of Census data), and 23% of working-age adults (19–64) had coverage all year yet were underinsured in 2024 (Commonwealth Fund). In a 2013–2016 survey of bankruptcy filers, 66.5% cited medical bills or illness-related income loss as a contributing factor (Himmelstein et al., AJPH 2019) — other research estimates a much smaller direct causal share.

Is anything being done to lower US healthcare costs?

Yes, but slowly. Reform is targeting specific layers — Medicare Drug Price Negotiation (IRA 2022, first prices effective 2026), the Hospital Price Transparency Rule, and the No Surprises Act — yet the core paradox persists: the US still has the highest spending and among the worst outcomes of peer nations.

Is US healthcare the most expensive in the world?

Among OECD countries, yes. At $14,775 per person in 2024 on the comparable basis — about 1.9× the $7,860 average of comparable wealthy countries — the US spends more on healthcare than any other OECD country, while ranking last of 10 high-income nations on the Commonwealth Fund's 2024 Mirror Mirror rankings.

Do Americans get better care for paying more?

No. Despite the highest spending, US life expectancy was 79.0 years in 2024 versus 84.1 in Japan (2023), and the system ranks 10th of 10 peers on overall performance — highest spending, worst peer outcomes.

Sources

Claims in this guide are drawn from government, intergovernmental, research and peer-reviewed sources, each linked to the specific document below.

  1. CMS — National Health Expenditure fact sheet$5.3 trillion, $15,474 per person and 18.0% of GDP in 2024; $4.9 trillion and 17.7% of GDP in 2023 (revised).
  2. Peterson-KFF Health System Tracker — How does health spending in the U.S. compare to other countries? (March 11, 2026)2024 per-person health consumption spending and % of GDP, US vs comparable countries (OECD data).
  3. Commonwealth Fund — Mirror Mirror 2024US 10th of 10 overall; last on access and health outcomes; 9th on administrative efficiency and equity; 2nd on care process.
  4. CDC NCHS — Data Brief 548: Mortality in the United States, 2024US life expectancy at birth 79.0 years (2024).
  5. OECD — Health at a Glance 2025 (November 2025), Table 1.6 and chapter 72024 health spending per person (USD, PPP) and share of GDP; provisional. US 14,885 / 17.2%, OECD 5,967 / 9.3%, Germany 9,365 / 12.3%, France 7,367 / 11.5%, UK 6,747 / 11.1%.
  6. OECD Health StatisticsLife expectancy (Japan 84.1); maternal mortality (US 17.9, Germany and Japan 4.4, 2024).
  7. KFF — Key Facts about the Uninsured Population26.7 million uninsured under-65s, 9.8% (2024).
  8. KFF — 2026 Employer Health Benefits Survey (October 22, 2026)Average family premium $28,303 (2026).
  9. Commonwealth Fund — The State of Health Insurance Coverage in the U.S.: 2024 Biennial Health Insurance Survey (November 2024)23% of adults ages 19–64 insured all year but underinsured (2024; Exhibit 1).
  10. KFF State Health Facts — Health Insurance Coverage of the Total PopulationEmployer coverage 48.6% of the US population (2024, Census ACS).
  11. Himmelstein, Campbell, Woolhandler — Annals of Internal Medicine, 2020Administration 34.2% of US health spending vs 17.0% in Canada (2017).
  12. RAND — International Prescription Drug Price Comparisons (2024, 2022 data)US prices 2.78× (all drugs) and 4.22× (brand-name, gross) those in 33 OECD countries.
  13. Cooper, Craig, Gaynor, Van Reenen — Quarterly Journal of Economics, 2019Monopoly hospital prices 12% higher than in markets with four or more rivals.
  14. Fulton — Health Care Market Concentration Trends in the United States. Health Affairs, 201790% of metropolitan hospital markets highly concentrated (2016).
  15. Mello, Chandra, Gawande, Studdert — Health Affairs, 2010Defensive medicine $45.6B; total liability-system cost $55.6B (2008 dollars).
  16. Federal Trade Commission — PBM Interim Staff Report, July 2024Top 3 PBMs administer about 79% of US prescription claims.
  17. PatientRightsAdvocate.org — Hospital Price Transparency Compliance Report (November 2024)21.1% of 2,000 reviewed hospitals fully compliant (34.5% in February 2024). Advocacy-group methodology.
  18. Papanicolas, Woskie, Jha — JAMA, 2018US spending gap driven mainly by prices, not utilization.
  19. Himmelstein, Lawless, Thorne, Foohey, Woolhandler — Medical Bankruptcy: Still Common Despite the Affordable Care Act. AJPH, 201966.5% of surveyed bankruptcy filers (2013–2016) cited medical bills or illness-related income loss as a contributing factor.
  20. Dobkin, Finkelstein, Kluender, Notowidigdo — The Economic Consequences of Hospital Admissions. American Economic Review, 2018Estimates a much smaller direct causal role of hospitalizations in bankruptcy.

Editorial Independence

Wellness Vision is an independent research platform. We receive zero revenue from clinics, insurers, pharmaceutical companies, PBMs, or referral networks. Claims are checked against the specific government, research and peer-reviewed documents linked above. Editorial decisions serve patient interests — not commercial ones.

AI-assisted research and production (Azure Neural TTS Dragon HD Emma2, DALL-E, Grok Imagine). Every figure is checked against the primary source it cites; the October 2026 source review is logged on our sources page.

Wellness Vision Editorial Policy

Wellness Vision does not book trips. We do not receive clinic referrals. We do not recommend specific providers, and we name none. Statistics come from the government, research and peer-reviewed sources listed above. This is a cost comparison, not medical advice: always consult a qualified, licensed healthcare provider before any medical decision.

You shouldn't have to go broke to feel whole.

“You shouldn't have to go broke to feel whole.”